Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
B
Brenda M. Gannon
Assistant Professor
Also affiliated: University of Maryland, Baltimore (2024); National Institute on Drug Abuse (2016–2017); The University of Texas at San Antonio Health Science Center (2016–2022); Louisiana State University in Shreveport (2021); Mercer University Health Sciences Center (2020–2021); Audie L. Murphy Memorial VA Hospital (2018); National Institute on Alcohol Abuse and Alcoholism (2016–2017); South Texas Veterans Health Care System (2017); Arkansas Department of Agriculture (2015); Louisiana State University Health Sciences Center New Orleans (2024); Louisiana State University Health Sciences Center Shreveport (2021)
Faculty Researcher
16 h-index
51 pubs
935 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Brenda M. Gannon's research focuses on the pharmacological effects and abuse liability of novel psychoactive substances, particularly synthetic cathinones and arylcyclohexylamines. Her work investigates the interactions of these compounds with monoamine transporters and their reinforcement properties in rodent models. Gannon has explored dose-response relationships for drug mixtures and examined how laboratory housing conditions can influence animal behavior and physiology. She has also contributed to understanding the development of cannabinoids as therapeutic agents and the role of the endocannabinoid system in alcohol dependence. Gannon collaborates with researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi, with whom she has co-authored nine publications. Her scholarship metrics include an h-index of 16, with 51 total publications and 921 total citations.
Metrics
- h-index: 16
- Publications: 51
- Citations: 935
Selected Publications
-
Interoceptive effects of N1-substituted lysergamides in rats: role of agonist affinity at 5-HT receptors and in vivo metabolism to lysergic acid diethylamide (LSD) (2026)
-
Behavioral and Pharmacokinetic Implications of Synthetic Cannabinoid Receptor Agonist and Benzodiazepine Co-Administration in C57BL/6 Mice (Abstract ID: 221452) (2026)
-
Effects of Psychedelics Lysergic Acid Diethylamide and <i>R</i> (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice (2026)
-
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations (2025)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
-
A “Furious” Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics (2024)
-
Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024)
-
The Development of Cannabinoids as Therapeutic Agents in the United States (2024)
-
Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917] (2024)
-
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents (2024)
-
Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones (2023)
-
Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety (2023)
-
Evaluation of morphine‐like effects of the mixed mu/delta agonist morphine‐6‐<i>O</i>‐sulfate in rats: Drug discrimination and physical dependence (2018)
-
Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice (2017)
-
Phencyclidine-like in vivo effects of methoxetamine in mice and rats (2017)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas for Medical Sciences
8 shared publications
In database
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- A “Furious” Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics
Showing 5 of 8 shared publications
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
4 shared publications
In database
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Christopher O. Godwin
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Heidi D. Hughes-Meredith
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Kenner C. Rice
National Institute on Alcohol Abuse and Alcoholism (US)
2 shared publications
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Hannah E. Shaw
University of Arkansas for Medical Sciences
2 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Ziva D. Cooper
Neurobehavioral Systems (US)
2 shared publications
- The Development of Cannabinoids as Therapeutic Agents in the United States
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
Donna Walther
National Institute on Drug Abuse (US)
1 shared publication
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Antonio Landavazo
RTI International (US)
1 shared publication
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Takato Hiranita
The University of Texas Health Science Center at San Antonio (US)
1 shared publication
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Bruce E. Blough
RTI International (US)
1 shared publication
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Michael H. Baumann
National Institutes of Health (US)
1 shared publication
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Dylan R. Patel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Theresa M. Carbonaro
United States Department of Justice
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Chad R. Johnson
University of Maryland, Baltimore (US)
1 shared publication
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Similar Researchers
Based on overlapping research topics
Catheryn D. Wilson
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
John T. Striednig
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Michael D. Berquist
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Mary E Shepard
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes